title: Drug transporter expression and localization in rat nasal respiratory and olfactory mucosa and olfactory bulb.
abstract: Uptake of drugs and other xenobiotics from the nasal cavity and into either the brain or systemic circulation can occur through several different mechanisms, including paracellular transport and movement along primary olfactory nerve axons, which extend from the nasal cavity to the olfactory bulb of the brain. The present study was conducted to expand knowledge on a third means of uptake, namely the expression of drug transporters in the rat nasal epithelium. We used branched DNA technology to compare the level of expression of nine transporters [(equilibrative nucleoside transporters (ENT)1 and ENT2; organic cation transporter (OCT)1, 2, and 3; OCTN1; organic anion-transporting polypeptide (OATP)3; and multidrug resistance (MRP)1 and MRP4] in nasal respiratory mucosa, olfactory mucosa, and olfactory bulb to the level of expression of these transporters in the liver and kidney. Transporters with high expression in the nasal respiratory mucosa or olfactory tissues were immunolocalized by immunohistochemistry. ENT1 and ENT2 expression was relatively high in nasal epithelia and olfactory bulb, which may explain the uptake of intranasally administered nucleoside derivatives observed by other investigators. OATP3 immunoreactivity was high in olfactory epithelium and olfactory nerve bundles, which suggests that substrates transported by OATP3 may be candidates for intranasal administration.
authors.affiliation: Department of Environmental Health, University of Cincinnati, Cincinnati, OH 45267-0056, USA. marybeth.genter@uc.edu
authors.forename: Mary Beth
authors.initials: MB
authors.lastname: Genter
authors.forename: Mansi
authors.initials: M
authors.lastname: Krishan
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Augustine
authors.forename: Nathan J
authors.initials: NJ
authors.lastname: Cherrington
mesh_terms: D000281:Administration, Intranasal; D000818:Animals; D001692:Biological Transport; D033705:Equilibrative Nucleoside Transport Proteins / Q000096:biosynthesis* / Q000235:genetics; D015870:Gene Expression; D007150:Immunohistochemistry; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000096:biosynthesis* / Q000235:genetics; D009297:Nasal Mucosa / Q000378:metabolism; D009705:Nucleosides / Q000008:administration & dosage / Q000493:pharmacokinetics; D009830:Olfactory Bulb / Q000378:metabolism*; D009831:Olfactory Mucosa / Q000378:metabolism*; D009928:Organ Specificity; D029362:Organic Anion Transporters, Sodium-Independent / Q000096:biosynthesis; D027701:Organic Cation Transport Proteins / Q000096:biosynthesis* / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D033705:Equilibrative Nucleoside Transport Proteins; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D009705:Nucleosides; D029362:Organic Anion Transporters, Sodium-Independent; D027701:Organic Cation Transport Proteins; C421143:Slco1a5 protein, rat